News About: Pharm. Industry
Ur calls for withdrawal of government's Package FTA Deal with US
Ur Joon-sun, newly elected chairman of the Korea Pharmaceutical Manufacturers Association, called for withdrawal of the Korean government's package deal'' policy with the United States in its last-ditch effort to esta...
Baraclude recommended as primary choice of B hepatitis therapy.
A revised U. S. therapeutic guideline for B viral hepatitis infection treatment has been introduced into Korea for the first time.
Prof. Emmet B. Keeffe of the medical center of Stanford University who established ...
Bukwang's Lebovir received grand prix in new drug development.
Lebovir, the 11th Korean new drug developed by Bukwang with 110 billion won of investment during the past 12 years from its preclinical, clinical, synthesis and dosage form
research and development received the gran...
GSK and MSD to compete vaccines in Korea.
Two leading vaccine manufacturers, GSK and MSD, may stage severe market competition with the cervical cancer and rotavirus vaccines in the world markets as well as Korea market during the times from the 2nd half of th...
GSK releases Avandaryl this month
GlaxoSmithKline (GSK) said on March 1 it has launched Avandaryl (rosiglitazone maleate and glimepiride) tablets containing 2 oral antidiabetic drugs used in the management of type 2 diabetes: Rosiglitazone maleate and...
Dong-A exports new antibiotic to US
Dong-A Pharmaceutical Co., the nation's largest drugmaker, said on February 27 that it had signed a contract with the U.S.-based Trius Therapeutics in San Diego, for the development and marketing of a novel antibiotic...
Il Yang to commercialize a new anti-leukemia drug soon.
Il Yang has visualized its experimental new drug "IY5511" for the treatment of leukemia with recent animal in-vivo study reports, showing about 20 times more potent than Gleevec.
According to the study conducted ...
26 pharmaceutical firms enjoy 9% growth in 2006 sales
The combined sales of major 26 pharmaceutical drugmakers listed on the main stock bourse posted 4.6 trillion won last year, up 8.9 percent compared with 4.3 trillion won from a year earlier, Yakup Shinmoon said ...
Ahngook chairman to lead KPMAUr Choon-sun, chairman of Ahngook Pharm, was unanimously elected as the new chairman of the Korea Pharmaceutical Manufacturers Association (KPMA), the nation's pharmaceutical lo...
|
KPMA to oppose against KORUS FTA deals on drugs.
The Korea Pharmaceutical Manufacturers Association (KPMA) indicated that the government should not use the pharmaceutical issue in the 8th KORUS FTA negotiation meeting as scheduled to hold in Seoul in coming March as...
